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ABSTRACT 
With the increasing use of neuroimaging studies, the discovery of incidental neoplastic lesions is 
becoming more frequent. However, standard procedures are lacking and little is known about 
their optimal management. We here present the case of a boy with a cerebellar mass incidentally 
discovered on a CT scan performed after head trauma. In another scan performed after another 
incident of head trauma 4 months earlier, the lesion could be seen after retrospective 
examination. In view of the asymptomatic clinical and stable radiological status and the 
presumed diagnosis of a low-grade glioma, a watch-and-wait strategy was elected. After clinical 
and radiological progression was observed, the tumour was resected, 2½ years after the initial 
imaging study. Histological evaluation revealed a WNT pathway-activated classical 
medulloblastoma. To our knowledge, this is the first description of such a long natural history 
and pre-symptomatic period of a medulloblastoma. The long period of stability followed by a 
period of accelerated tumour growth is compatible with increasing biological aggressiveness, 
possibly related to the stepwise accumulation of genetic changes.  
 
 
INTRODUCTION 
 
Due to increasing use of neuroimaging studies, the number of incidentalomas, i.e. incidentally 
discovered abnormal findings unrelated to the purpose of the examination, has been rising, with 
an overall prevalence ranging from 0.1 to 1%[13, 16]. After the detection of a lesion, standard 
procedures are lacking and little is known about the optimal management. In many instances, the 
neuroimaging features are not diagnostic and histopathologic diagnosis comprises a diverse 
spectrum of entities. Here we present the case of a boy with a cerebellar incidentaloma, which 
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was resected after 2½ years of observation, and surprisingly, yielded the diagnosis of 
medulloblastoma (MB). 
 
 
CASE REPORT 
 
After sustaining a minimal head trauma in April 2006, a 6½ year-old boy underwent a cranial CT 
scan in another institution, which at that time was judged as normal. Fourteen months later, 
during the investigation of a similar head trauma, another CT scan was performed, which showed 
a circumscribed, mainly hyperdense vermian mass with a diameter of 2 cm without any evidence 
of obstructive hydrocephalus (Figure 1). Retrospectively, the identical finding was identified on 
the first scan. The patient was then referred to our institution for neuropaediatric evaluation, 
where a MRI showed an inhomogenously contrast enhancing lesion without perifocal oedema 
with an inhomogeneous hypo- and hyperintense signal in T2 and FLAIR sequences, and a larger 
proportion showing no diffusion restriction with a correspondingly elevated ADC value. The 
patient complained of headache, tiredness and dizziness, which could not be explained by the 
lesion, and which subsequently resolved spontaneously. The neurological examination was 
normal. Since the presumptive diagnosis was a low-grade glioma, a wait-and-see strategy was 
chosen. A follow-up MRI in December 2007 showed discrete signs of progression, with 
increased contrast enhancement and extension of the tumour into the right foramen of Luschka 
and left cerebellar grey matter. Despite radiographic evidence of progression, the patient 
remained asymptomatic. An MRI performed 4 months later was unchanged when compared to 
the previous MRI. At that time, the patient complained of blurred vision, loss of balance and 
coordination deficits. On neurological examination, moderate truncal ataxia, bilateral dysmetria, 
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right-sided dysdiadochokinesis, and nystagmus were noted. In addition, right monocular double 
vision and visual acuity that fluctuated between 0.3 and normal were documented; however, not 
all of the findings could be explained by the tumour. Clinically, fatigue and gait disturbance 
persisted, and a subsequent MRI in December 2008 showed further tumour progression. 
Accordingly, the tumour was partially resected in January 2009, with the histological diagnosis of 
a classical MB (Figure 2). The MIB-1 proliferation index was 10 percent, and more than 10 
percent of tumour cells showed strong nuclear immunoreactivity for beta-catenin, and a CTNNB1 
mutation (S37P) was found, corresponding to medulloblastoma of the WNT subgroup[15]. 
Immunohistochemical analyses for hedgehog target genes as well as genomic and 
immunohistochemical analyses for c-myc amplification and target genes were negative. There 
was no evidence of micro- or macroscopic CNS metastases. The patient received craniospinal 
radiotherapy with concomitant vincristine followed by 8 chemotherapy cycles with cisplatin, 
lomustine and has stable residual disease for more than 3 years. 
 
 
DISCUSSION 
 
To our knowledge, this is the first description of such a long natural history and pre-symptomatic 
period in a patient with an untreated MB that was incidentally discovered on imaging. Due to the 
incidental nature of its discovery, the stable size during the 14 months interval between the first 
and the second CT scan, and the lack of neurological signs or symptoms (and despite an 
unequivocal hyperdensity on unenhanced CT, which is suspicious for a tumour with increased 
cellular density) the working diagnosis was low-grade glioma, which prompted a wait-and-see 
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approach. Surgery was only performed after clear clinical and radiological progression, altogether 
2½ years after the first CT scan.  
 
In most instances, the appearance of neurological symptoms precedes the radiological diagnosis 
of a posterior fossa tumour, followed by immediate surgical extirpation. Therefore, in contrast to 
the reported case, the kinetics of tumour growth before the appearance of the first symptom(s) are 
unknown. Accordingly, only the length of the prediagnostic symptomatic interval (PSI) can 
provide some indirect evidence regarding the kinetics of tumour growth: Not only are differences 
documented between different types of brain tumours, with malignant tumours (e.g. MBs) having 
shorter PSIs than low-grade tumours[4, 10, 12, 17, 19], but considerable variability is seen within 
the patient group with MB[2, 8]: In a large prospective series, we found PSIs ranging from 0 to 
24 months, with a median of 2 months. Interestingly, the group of patients with the longest PSIs 
had lower stage disease at diagnosis and a better overall survival probability than that with 
shorter PSIs[6]. The likely explanation for these results probably lies in the broad spectrum of 
biologic behaviour within the whole group of MB[3, 15]. The present tumour can be classified 
histologically as WNT pathway-activated MB. This MB subtype is associated with a favourable 
prognosis[5, 15]. One could speculate that the tumour acquired a stepwise accumulation of 
genetic aberrations over time, which – after a relatively stable phase - resulted in accelerated 
growth. This hypothesis is consistent with the findings of an accumulation of such aberrations in 
relapsed medulloblastoma when compared to their corresponding primary tumours[9]. 
 
Due to the more frequent use of neuroradiologic imaging, the number of neoplastic 
incidentalomas has been steadily rising[13, 16]. While for a definitive histological diagnosis of a 
posterior fossa tumour a neuropathological examination is needed, neuroimaging can offer a 
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certain diagnostic guidance, notably regarding the distinction between a high and a low 
cellularity. In the case of this patient, due to the long lasting constant size and the lack of clinical 
symptoms, a low grade tumour was suspected, even if on the basis of the increased CT-density 
this working diagnosis would have to be doubted. Low-grade gliomas are tumours with a low 
cellularity and therefore exhibit low CT-density values[11], while the typical CT-appearance of 
medulloblastoma is hyperdense before contrast medium application[14, 18]. CT-density still 
remains a very good tool to differentiate between lesions with low and high cellular density[1]. In 
magnetic resonance imaging, comparison of apparent diffusion coefficient parameters revealed 
distinctive values in different entities of posterior fossa tumours in single centre reports[7, 20]. 
 
 
CONCLUSION 
 
This is the first description of MB with such a long natural history diagnosed as an incidentaloma 
that was followed according to a wait-and-see approach. During the long period of clinical and 
radiological stability preceding the radiological and clinical progression, the working diagnosis 
was low-grade glioma, despite a non-fitting hyperdensity of the tumour on CT. We suspect an 
accumulation of genetic aberrations over time leading to a change of growth behaviour. However, 
as the tumour was not biopsied at the time of radiological detection, this remains speculative. 
 
There are no evidence-based guidelines for the management of neoplastic CNS incidentalomas. 
Not only a precise histological diagnosis can often not be made on radiological grounds, but also 
a neoplastic incidentaloma might clinically behave differently compared to a lesion of the same 
histology diagnosed on the basis of symptoms. Whereas a delay in treatment in some patients 
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may have negative consequences, unnecessary surgical exploration may also be associated with 
considerable morbidity (e.g. CNS lesions, haemorrhage). Therefore, a case-by-case evaluation by 
an interdisciplinary tumour board is recommended, with the consideration of parameters such as 
the radiological nature of the lesion, the differential diagnosis, the evolution, and the clinical state 
of the patient. 
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FIGURE LEGENDS 
 
Figure 1(A-F): Serial images illustrating the natural growth behaviour with a prolonged period 
of stability followed by progression of a medulloblastoma initially discovered as an 
incidentaloma (arrow). 1A CT scan April 2006, 1B CT scan June 2007 (stable disease), 1C MRI 
(T2) July 2007 (stable disease), 1D MRI (T2) December 2007 (progressive disease), 1E MRI 
(T2) April 2008 (stable disease compared to 1D), 1F MRI (T2) December 2008 (progressive 
disease) 
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Figure 2: Medulloblastoma: Cerebellar cortex infiltrated by densely packed monomorphous 
tumour cells with moderate nuclear pleomorphism and scant cytoplasm  
 
 
 
 
